Searched for
THERAPEUTIC AREAS
Wegovy maker Novo Nordisk faces investor pressure to find growth beyond weight-loss drugsFacing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...- BRICS adopts New Delhi Declaration: Inside the 140-point document on Global South's ambitionsBRICS leaders adopted the New Delhi Declaration at the 18th summit, reaffirming their commitment to cooperation, multilateralism and a more...
- Leaders of BRICS countries call for stronger cooperation in health, endorse initiatives on tuberculosisBRICS leaders agreed to strengthen health cooperation and share best practices. They endorsed initiatives focusing on tuberculosis and digi...
- Adobe’s next boss joins a powerful club: Meet the Indian-origin CEOs running the world’s biggest companiesAdobe’s next CEO Anil Chakravarthy is joining a powerful club. From Microsoft and Google to Chanel, FedEx and Micron, Indian-origin executi...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe Indian market was under pressure on Thursday, particularly at the index level. Rising crude-oil prices are an obvious concern, but dome...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIn the equity market, it is generally good to keep one eye on risk management. But there are times when it becomes a must-do. We are curren...
- Assam CM calls for IIT Guwahati to emerge as knowledge partner of the Northeast IndiaAssam Chief Minister Himanta Biswa Sarma urged IIT Guwahati to enhance its role as a development partner. He emphasized collaboration in ad...
- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
- After 200+ applications and 15+ interviews, former corporate employee takes $11/hour dishwashing jobA 29-year-old former corporate employee laid off in April says he has submitted more than 200 applications and attended over 15 interviews ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the possibility of hostilities resuming in the Gulf region, focus on risk management in the market. Why? Because fresh hostilities wi...
- ET Startup Awards 2026 | Top Innovator: Deeptech startup Theranautilus’ micro robots score big winDeeptech startup Theranautilus has won the Top Innovator award at the ET Startup Awards 2026 for its work on microscopic robots that can na...
- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%Given current market conditions, better stick with stocks that offer some comfort. It could be valuation, or growth purely dependent on dom...
- Lord’s Mark Industries announces license for biomescan analytics platformLord's Mark Industries has obtained a license for its groundbreaking Biomescan Analytics Platform, which specializes in assessing the gut m...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Market breadth is important, especially at this point of time. It is a better indicator of both underlying sentiment and what is likely in ...
- Disease Outbreak in Congo: Ebola death toll crosses 2,000—What Americans need to knowAn Ebola outbreak in the Democratic Republic of Congo has surpassed two thousand confirmed deaths. This outbreak involves a different virus...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 20%It was after quite some time that market breadth, always a better indicator of underlying sentiment, was positive for a few trading session...
- India's Second Leapfrog: From sick-care to AI-native health infrastructureJust as India bypassed copper landlines to become a global mobile data leader, it can now bypass the West's CPT-coded sick-care bureaucracy...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe next time uncertainty over the firing of missiles in the Gulf region makes you anxious, remember this: It is not the first time that gl...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
Load More
